Hain Lifescience GmbH manufactures and supplies modern diagnostic systems and therapeutic agents. The produce human molecular biological and microbiological diagnostic tests, among other they also offer tests for: Enterococci, lactose intolerance, Mycobacteria, paradontosis, MRSA.

With the acquisition of Hain Lifescience GmbH, Bruker further expands its product portfolio in the area of Molecular Diagnostics. The business of Hain Lifescience will be continued as part of the Bruker Corporation.